BSE filing, NSE: MOLDTKPAC. Summary written from the filing by ALFA Finder's alert engine.
Mold-Tek Packaging Ltd: key numbers
- Share price
- ₹272.85
- Market cap
- ₹1,813 Cr
- Revenue (annual)
- ₹886.6 Cr
- Net profit (annual)
- ₹72.87 Cr
- P/E (TTM)
- 23.8×Sector 45.0×
- Promoter holding
- 33.17%-0.04% QoQ
- FII holding
- 7.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mold-Tek Packaging Ltd
All →Mold-Tek Packaging Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs274.23 Cr (+31% YoY), PAT Rs21.07 Cr (+36%), EBITDA Rs51.27 Cr (+30%) at 18.70% margin. H1 revenue +28%, PAT +23%.
Mold-Tek Packaging Q2 FY27 Results: Net Profit ₹21.1 Cr, Up 36.1% YoY
Mold-Tek Packaging Ltd reported revenue from operations of ₹274.2 Cr (+30.7% YoY) and net profit of ₹21.1 Cr (+36.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.1 Cr · +36.1% YoY
Mold-Tek Packaging Board Meeting Date
Mold-Tek Packaging's Board Meeting is scheduled for 2 November 2026 to approve unaudited financial results for the quarter and half-year ended September 2026. No financial figures are disclosed in this advance notice.
Mold-Tek Packaging Other Announcement
Mold-Tek Packaging Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with regulatory reporting requirements.
Mold-Tek Packaging Bonus Issue
Mold-Tek Packaging Limited approved the allotment of 3,32,28,914 bonus equity shares in a 1:1 ratio. This increases the company's paid-up equity capital to Rs. 33.23 Crore.
Mold-Tek Packaging Legal & Regulatory
Mold-Tek Packaging received an Income Tax demand notice of ₹0.36 Crore for the Assessment Year 2021-22. The company is currently responding to the relevant authorities.
- Value
- ₹0.36 Cr
- From
- Income Tax Department
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.
Eureka Forbes Results Update
Eureka Forbes reported Q2 FY27 revenue of ₹889.6 Cr and PAT of ₹73.3 Cr, both up ~19% YoY. EBITDA margin hit a lifetime high of 13.6%.